Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in ST-Elevation Myocardial Infarction (STEMI)
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.
Also called NCT01324453
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 103 participants
- Registry
-
NCT01324453
-
- Other papers using this trial's data
- NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01324453. Randomized; no masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2016-11 (actual). Results posted on 2018-04-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in ST-Elevation Myocardial Infarction (STEMI)
- Condition
- Acute Myocardial Infarction
- Intervention (Procedure)
- Post Conditioning + Primary PCI
- Intervention (Procedure)
- Standard Primary PCI
- Lead sponsor
- Minneapolis Heart Institute Foundation
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
Record details
- Record id
cardio:ct-nct01324453- Content hash
181209d853c34d913424928b68b0ea45648024fc2c5a15952bf18881714b5b8a